8 followers
RT @FrontImmunol: New Research: Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes: Antigen-sp…
RT @FrontImmunol: New Research: Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes: Antigen-sp…
RT @FrontImmunol: New Research: Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes: Antigen-sp…
New Research: Overcoming Obstacles in the Development of Antigen-Specific Immunotherapies for Type 1 Diabetes: Antigen-specific immunotherapy (ASI) holds great promise for type 1 diabetes (T1D). Preclinical success for this approach has been… https://t.co/